Roche Completes Acquisition of BioVeris
With its acquisition of BioVeris complete, Roche Diagnostics is the patent owner for electrochemiluminescence (ECL) technology and can expand its immunochemistry business from the human diagnostics field into new market segments such as life sciences research, life science development, patient self-testing, veterinary testing, drug discovery, drug development, and clinical trials.
Read More